⌘K

Login Start Free

Home/Filings/4/0001214659-18-000578

4//SEC Filing

Reisman Neil 4

Accession 0001214659-18-000578

CIK 0001576263other

View on SEC.gov Company Profile

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 6:00 PM ET

Size

5.3 KB

Accession

0001214659-18-000578

Insider Transaction Report

Form 4

Period: 2018-01-18

Mirati Therapeutics, Inc.MRTX

10% Owner

Transactions

Award
Non-Qualified Stock Option (right to buy)
2018-01-18+10,000→ 10,000 total
Exercise: $27.00Exp: 2028-01-17→ Common Stock (10,000 underlying)

Footnotes (1)

[F1]The shares subject to the Option vest and become exercisable in 12 equal monthly installments following the date of grant.

Documents

1 file

4
marketforms-40826.xmlPrimary
PRIMARY DOCUMENT

Issuer

Mirati Therapeutics, Inc.

CIK 0001576263

Entity typeother

Related Parties

1

filerCIK 0001465834

Filing Metadata

Form type: 4
Filed: Jan 21, 7:00 PM ET
Accepted: Jan 22, 6:00 PM ET
Size: 5.3 KB

View on SEC.gov